Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel.
The percutaneous absorption of diclofenac was studied in ten healthy volunteers treated with Emulgel containing 1.16% diclofenac diethylammonium for 8 d as follows: a single application of 5 g Emulgel on days 1 and 8, and two applications d-1 on days 2-7. Plasma concentration profiles of unchanged diclofenac and urinary concentrations of total diclofenac and metabolites (sum of free and conjugated) were determined. High inter-individual variations in plasma and urine data were recorded, due probably to the permeability and the hydration of the skin. Steady state was reached after 2 d of twice-daily administration. Plasma concentrations were low but remained in the range 10-50 nmol L-1 over the full day for most of the subjects, indicating prolonged absorption from the application site.
Sioufi
A
A
Laboratoires Ciba-Geigy, Biopharmaceutical Research Centre, Rueil-Malmaison, France.
Pommier
F
F
Boschet
F
F
Godbillon
J
J
Lavoignat
D
D
Salliere
D
D
D000287:Administration, Topical; D000328:Adult; D004008:Diclofenac / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004655:Emulsions; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D012869:Skin Absorption
D004655:Emulsions; D005782:Gels; D004008:Diclofenac